4-(2-氯砒啶-3-基磺酰)吗啉 | 60597-72-0

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 4-(2-氯砒啶-3-基磺酰)吗啉
• 中文别名: 4-(2-氯吡啶-3-基磺酰)吗啉
• 英文名称: 4-((2-chloropyridin-3-yl)sulfonyl)morpholine
• 英文别名: 4-(2-chloropyridin-3-yl)sulfonylmorpholine
• CAS: 60597-72-0
• 化学式: C₉H₁₁ClN₂O₃S
• 分子量: 262.717
• InChiKey: YCOYJCWIMIBSNF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  67.9
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2934999090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-(2-Chloropyridin-3-ylsulfonyl)morpholine
Synonyms: 4-[(2-Chloropyridin-3-yl)sulfonyl]morpholine

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-(2-Chloropyridin-3-ylsulfonyl)morpholine
CAS number: 60597-72-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H11ClN2O3S
Molecular weight: 262.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(2-氯砒啶-3-基磺酰)吗啉 在 三乙胺 作用下， 以 乙醇 、 水 为溶剂， 反应 4.0h， 生成 1-methyl-8-(morpholinosulfonyl)-[1,2,4]triazolo[4,3-a]pyridin-1-ium-3-thiolate
  参考文献：
  名称：

  Synthesis and properties of pyridine- and s-triazolo[4,3-a]pyridinesulfonamides

  摘要：

  DOI：

  10.1007/bf00765912
• 作为产物：
  描述：

  2-氯吡啶-3-磺酰氯 以45%的产率得到
  参考文献：
  名称：

  POSTOVSKIJ I. YA.; KOTOVSKAYA S. K.; MOKRUSHINA G. A.; ILENKO V. I.; PLAT+, XIM.-FARMATS. ZH., 1980, 14, HO 2, 50-54

  摘要：

  DOI：

文献信息

• Compounds for the Treatment of Hepatitis C
  申请人：Bergstrom Carl P.

  公开号：US20090042860A1

  公开（公告）日：2009-02-12

  The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

  这项发明涵盖了公式I的化合物，以及使用这些化合物的组合物和方法。这些化合物对丙型肝炎病毒（HCV）具有活性，并可用于治疗感染HCV的人。
• A Novel Series of [1,2,4]Triazolo[4,3-a]Pyridine Sulfonamides as Potential Antimalarial Agents: In Silico Studies, Synthesis and In Vitro Evaluation
  作者：Veronika R. Karpina、Svitlana S. Kovalenko、Sergiy M. Kovalenko、Oleksandr G. Drushlyak、Natalya D. Bunyatyan、Victoriya A. Georgiyants、Vladimir V. Ivanov、Thierry Langer、Louis Maes

  DOI：10.3390/molecules25194485

  日期：——

  new and potent antimalarial drugs, we designed the virtual library with three points of randomization of novel [1,2,4]triazolo[4,3-a]pyridines bearing a sulfonamide fragment. The library of 1561 compounds has been investigated by both virtual screening and molecular docking methods using falcipain-2 as a target enzyme. 25 chosen hits were synthesized and evaluated for their antimalarial activity in vitro

  为了开发新的和有效的抗疟疾药物，我们设计了虚拟库，其中包含带有磺胺片段的新型 [1,2,4] 三唑并 [4,3-a] 吡啶的三个随机点。使用 falcipain-2 作为目标酶，通过虚拟筛选和分子对接方法对 1561 种化合物的库进行了研究。合成了 25 个选定的命中并评估了它们在体外针对恶性疟原虫的抗疟活性。3-乙基-N-(3-氟苄基)-N-(4-甲氧基苯基)-[1,2,4]三唑并[4,3-a]吡啶-6-磺酰胺和2-(3-氯苄基)-8 -(piperidin-1-ylsulfonyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one 显示出良好的体外抗疟活性，抑制浓度 IC50 分别为 2.24 和 4.98 μM。
• 10.1021/acs.orglett.4c01908
  作者：Pincekova, Lucia、Merot, Aurélien、Schäfer, Gabriel、Willis, Michael C.

  DOI：10.1021/acs.orglett.4c01908

  日期：——

  starting materials in the synthesis of sulfonamides, which are in-demand motifs in drug discovery chemistry. Despite their importance, the number of different synthetic approaches to sulfonyl chlorides is limited, and most of them rely on traditional oxidative chlorination chemistry from thiol precursors. In this report, we disclose a novel Sandmeyer-type sulfonyl chloride synthesis from feedstock anilines

  磺酰氯不仅在保护基团化学中发挥着至关重要的作用，而且还是磺酰胺合成中的重要起始原料，而磺酰胺是药物发现化学中急需的基序。尽管磺酰氯很重要，但不同合成方法的数量有限，其中大多数依赖于硫醇前体的传统氧化氯化化学。在本报告中，我们公开了一种在 HCl 和 Cu 催化剂存在下，由原料苯胺和 DABSO（用作稳定的 SO 2替代物）进行的新型桑德迈尔型磺酰氯合成方法。该方法适用于多种苯胺，并允许在水性后处理后分离磺酰氯，或在桑德迈尔反应完成后通过简单添加胺将磺酰氯直接转化为磺酰胺。该方法的可扩展性在 20 g 规模上得到了证明，并且以 80% 的产率和优异的纯度分离出相应的杂环磺酰氯。
• THUNUS L.; LAPIERE C.-L., ANN. PHARM. FRANC. <APFR-AD>, 1975 (1976), 33, NO 12, 663-669
  作者：THUNUS L.、 LAPIERE C.-L.

  DOI：——

  日期：——
• TETRACYCLIC COMPOUNDS FOR THE TREATMENT OF HEPATITIS C
  申请人：Bristol-Myers Squibb Company

  公开号：EP2178878B1

  公开（公告）日：2012-03-28